FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF spotlight on scientific literature: “Why children have to wait years for new drugs”
This recent article is part of Nature Outlook: Children‘s health and focuses on the lack of medicines approved for paediatric use. According [...]
First gene therapy to treat haemophilia B
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Hemgenix (etranacogene dezaparvovec), the the first gene therapy [...]
Event: The next steps for a real European Health Union – Delivering patient care through digital solutions
This in-person event, organized by the European Association of E-Pharmacies (EAEP) will be held on Thursday, 27 October at TownHall Europe (Square [...]
Calls Horizon Europe Cluster Health
We are excited to announce that new calls of the Horizon Europe Cluster Health with a budget of €67 million, [...]
Open access policy monitoring report of Horizon 2020 is out!
The report examines, monitors, and quantifies compliance with the open access requirements of Horizon 2020 for both publications and research [...]
6th European Conference on Clinical Research
The 6th European Conference on Clinical Research organized by the European CRO Federation (EUCROF) took place on 07 & 08 [...]
Pharmaceutics special issue dedicated to EPTRI
The Pharmaceutics journal dedicated a special issue, the “Scientific Highlights in the First European Paediatric Translational Research Infrastructure (EPTRI) Open [...]
HEPATOMICS: CVBF will contribute to the new project selected by the Cypriot Research Promotion Foundation
The Cypriot Research Promotion Foundation (RPF) selected for funding the project “HEPATOMICS”, aimed to identify novel peripheral blood biomarkers for liver damage in b-thalassaemia through [...]
CVBF is involved in the multinational clinical study SAIL
SAIL is an observational study to assess the effectiveness, safety profile and real-life prescribing and utilization patterns of a monoclonal antibody in patients with moderate [...]
A new project for CVBF: SINERGY – Toward extracellular vesicle-based therapeutics for the treatment of bronchopulmonary dysplasia
Fondazione Città della Speranza-Onlus awarded the project “SYNERGY - toward extracellular vesicle-based therapeutics for the treatment of bronchopulmonary dysplasia”. The project, started in 2019, aims [...]
Share4Brain project was kicked off: sharing good practises on brain research
On 16th and 17th March, 2020 the new project Sharing Good practices for Brain Education in Europe (Share4Brain) was kicked off. In light of the [...]
New Publication: IntechOpen Journal. Chapter” Challenges and New Frontiers in the Paediatric Drug Discovery and Development”
Are you interested in paediatric drug discovery? You might find of interest the chapter “Challenges and New Frontiers in the Paediatric Drug Discovery and Development” [...]
New Publication: The Lancet Haematology Journal. “Evaluation of the effectiveness and safety of deferiprone compared to deferasirox in pediatric patients with hemoglobinopathies (DEEP-2)”
We are happy to inform you that the study entitled "Evaluation of the effectiveness and safety of deferiprone compared to deferasirox in pediatric patients with [...]